Therapy Type and Site of Metastases Factor into HR+, HER2+ mBC Treatment
Ian Krop, MD, PhD (Moderator) Professor of Internal Medicine (Medical Oncology) Yale School of Medicine Director, Clinical Trials Office Chief Clinical Research Officer Associate Director, Clinical Sciences Yale Cancer Center New Haven, CT CASE SUMMARY A …